You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection
Molecules Banner
Clinical Lentivirus/AAV Manufacturing Facility Image 1

Clinical Lentivirus/AAV Manufacturing Facility

Challenge from the Client

Our client required an "out of the box," fast-track execution strategy to bring their clinical gene therapy manufacturing facility from business case to installation and operational qualification in 12 months.

Our Approach & Solution

IPS proposed their iCON delivery strategy, an offsite fabricated modular solution composed of a series of cleanroom "boxes" or PODs, engineered around the clients manufacturing process. The iCON team took their pre-engineered ÜBERcellFLEX24 modules and optionalized them to meet the gene therapy process requirements, effectively shaving several months off the design and fabrication schedule. The ÜBERcellFLEX units were constructed and FAT'd in a factory in Ireland before being shipped to the construction site in Europe.

The Results

Our client was able to fast-track their project in an adjacent factory model to their normal business operations. They were able to procure a single source EPCMV solution for the entire project that included both onsite and offsite design, procurement, construction and qualification.

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue